INR 749.5
(-0.43%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 289.04 Million INR | 0.28% |
2022 | 288.25 Million INR | 10.86% |
2021 | 260 Million INR | 48.93% |
2020 | 174.58 Million INR | -26.38% |
2019 | 237.15 Million INR | 62.7% |
2018 | 145.76 Million INR | 40.73% |
2017 | 103.57 Million INR | 3.31% |
2016 | 100.25 Million INR | 11.73% |
2015 | 89.73 Million INR | 4.18% |
2014 | 86.13 Million INR | -1.25% |
2013 | 87.22 Million INR | -14.82% |
2012 | 102.4 Million INR | -22.18% |
2011 | 131.6 Million INR | 27.48% |
2010 | 103.23 Million INR | 41.24% |
2009 | 73.09 Million INR | 37.62% |
2008 | 53.11 Million INR | -43.52% |
2007 | 94.03 Million INR | 6.1% |
2006 | 88.62 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q3 | - INR | -100.0% |
2023 Q4 | 289.04 Million INR | 0.0% |
2023 FY | 289.04 Million INR | 0.28% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 308.9 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 288.25 Million INR | 10.86% |
2022 Q4 | 288.25 Million INR | 0.0% |
2022 Q2 | 303.94 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 260 Million INR | 48.93% |
2021 Q2 | 219.32 Million INR | 0.0% |
2021 Q4 | 260 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 174.58 Million INR | -26.38% |
2020 Q2 | 134.4 Million INR | 0.0% |
2020 Q4 | 174.58 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 237.15 Million INR | 0.0% |
2019 Q2 | 214.8 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 237.15 Million INR | 62.7% |
2018 Q1 | - INR | -100.0% |
2018 FY | 145.76 Million INR | 40.73% |
2018 Q4 | 145.76 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 169.43 Million INR | 0.0% |
2017 Q4 | 103.57 Million INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 145.94 Million INR | 0.0% |
2017 FY | 103.57 Million INR | 3.31% |
2016 FY | 100.25 Million INR | 11.73% |
2016 Q4 | 100.25 Million INR | 0.0% |
2015 FY | 89.73 Million INR | 4.18% |
2014 FY | 86.13 Million INR | -1.25% |
2013 FY | 87.22 Million INR | -14.82% |
2012 FY | 102.4 Million INR | -22.18% |
2012 Q2 | 152.08 Million INR | 0.0% |
2012 Q4 | 102.4 Million INR | 0.0% |
2011 FY | 131.6 Million INR | 27.48% |
2010 FY | 103.23 Million INR | 41.24% |
2009 FY | 73.09 Million INR | 37.62% |
2008 FY | 53.11 Million INR | -43.52% |
2007 FY | 94.03 Million INR | 6.1% |
2006 FY | 88.62 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Ajanta Pharma Limited | 8.28 Billion INR | 96.511% |
Sigachi Industries Limited | 707.2 Million INR | 59.128% |
Bal Pharma Limited | 878.11 Million INR | 67.083% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -176.396% |
Medico Remedies Limited | 163.37 Million INR | -76.926% |
Lasa Supergenerics Limited | 190.43 Million INR | -51.783% |
Venus Remedies Limited | 1.21 Billion INR | 76.247% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Alpa Laboratories Limited | 136.65 Million INR | -111.519% |
Nectar Lifesciences Limited | 7.09 Billion INR | 95.924% |
Shilpa Medicare Limited | 3.44 Billion INR | 91.62% |
Aarti Drugs Limited | 4.85 Billion INR | 94.051% |
Lupin Limited | 49.53 Billion INR | 99.417% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.705% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.16% |
Windlas Biotech Limited | 621.89 Million INR | 53.521% |
Suven Life Sciences Limited | 7.08 Million INR | -3979.704% |
Eris Lifesciences Limited | 1.89 Billion INR | 84.709% |
Valiant Laboratories Limited | 100.15 Million INR | -188.603% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 94.248% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 91.964% |
Ipca Laboratories Limited | 24.71 Billion INR | 98.83% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 75.597% |
Achyut Healthcare Limited | 568 Thousand INR | -50788.556% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.707% |
Bajaj HealthCare Limited | 1.44 Billion INR | 79.933% |
RPG Life Sciences Limited | 1.01 Billion INR | 71.381% |
Mankind Pharma Limited | 15.53 Billion INR | 98.139% |
Laurus Labs Limited | 18.45 Billion INR | 98.434% |
Piramal Pharma Limited | 21.75 Billion INR | 98.672% |
Syncom Formulations (India) Limited | 210.81 Million INR | -37.109% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 98.732% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 98.241% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 98.85% |
Unichem Laboratories Limited | 7.04 Billion INR | 95.898% |
Sequent Scientific Limited | 3.46 Billion INR | 91.652% |
Novartis India Limited | 448.6 Million INR | 35.567% |
Wanbury Limited | 360.23 Million INR | 19.761% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 87.498% |
Wockhardt Limited | 6.4 Billion INR | 95.484% |
Themis Medicare Limited | 705.74 Million INR | 59.044% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -92.737% |
Jubilant Pharmova Limited | 12.89 Billion INR | 97.759% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 95.664% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.545% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.092% |
NATCO Pharma Limited | 7 Billion INR | 95.874% |
Gufic Biosciences Limited | 2 Billion INR | 85.582% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 93.196% |
Ind-Swift Limited | 640.91 Million INR | 54.901% |
Procter & Gamble Health Limited | 1.09 Billion INR | 73.509% |
FDC Limited | 3.88 Billion INR | 92.567% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -195.054% |
Granules India Limited | 13 Billion INR | 97.777% |
Medicamen Biotech Limited | 593.75 Million INR | 51.319% |
Alkem Laboratories Limited | 26.61 Billion INR | 98.914% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 87.316% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -1033.651% |
Brooks Laboratories Limited | 96.1 Million INR | -200.752% |
Megasoft Limited | - INR | -Infinity% |
ZIM Laboratories Limited | 812.62 Million INR | 64.431% |
Strides Pharma Science Limited | 11.26 Billion INR | 97.434% |
Neuland Laboratories Limited | 3.5 Billion INR | 91.751% |
Morepen Laboratories Limited | 2.48 Billion INR | 88.373% |
Hikal Limited | 3.03 Billion INR | 90.483% |
Indoco Remedies Limited | 3.53 Billion INR | 91.813% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 95.504% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -624.792% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 76.622% |
Hester Biosciences Limited | 755.81 Million INR | 61.757% |